Dermatology Month in Review: January 2024
January’s Dermatology Month in Review features 2 major FDA decisions, positive results on a new assessment tool, an evaluation of climate change’s impact on eczema, and more.
Source: hcplive.com
Markd Kaufmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Markd Kaufmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Markd Kaufmann Today - Breaking & Trending Today
FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum
Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.
Source: pharmacytimes.com
At-Home Treatment for Molluscum Contagiosum Wins FDA Approval
Berdazimer gel led to 30% complete/near-complete clearance after 12 weeks in randomized trials
Source: medpagetoday.com
FDA Approval of Topical Berdazimer Gel Announced for Molluscum Contagiosum
The FDA decision on berdazimer gel, 10.3%, represents the second approved treatment for the viral-borne skin disease.
Source: hcplive.com
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum
ZELSUVMI™ is expected to be commercially available during the second half of 2024 ...
Source: marketscreener.com